Varicella Vaccine Allergy: Why Gelatin — Not Egg — Is the Real Concern
Varicella vaccine allergy is almost always caused by hydrolyzed gelatin rather than the virus itself or any egg protein. Varivax contains 8.3 to 12.0 mg of porcine hydrolyzed gelatin per dose and is grown in MRC-5 human diploid cells, which means it contains no egg protein at all. The live-attenuated Oka strain is pediatric, contraindicated in pregnancy and immunocompromise, and is completely different from the modern recombinant Shingrix zoster vaccine.
Free · 5 min · Insurance accepted
Key facts
Varivax (varicella vaccine) contains 8.3–12.0 mg of porcine hydrolyzed gelatin per dose — gelatin IgE allergy is the primary mechanism for rare anaphylactic reactions to this vaccine.
Varivax is produced in MRC-5 human diploid cells — it contains no egg proteins, making egg allergy completely irrelevant to varicella vaccine safety.
Anaphylaxis after varicella vaccine occurs at approximately 1 case per million doses — the same low rate as other childhood vaccines with gelatin content.
Children with gelatin allergy require allergist consultation before MMR, MMRV, and varicella vaccines because all three contain porcine hydrolyzed gelatin as a stabilizer — the same allergen across multiple immunizations.
Kelso et al., AAAAI Adverse Reactions to Vaccines Practice Parameter, 2012
What Is Varicella Vaccine Allergy?
Varicella vaccine allergy is an IgE-mediated immediate hypersensitivity reaction to an excipient in Varivax (Merck) or the combined MMRV product (ProQuad), almost always caused by hydrolyzed gelatin rather than the viral antigen or any egg protein.
The US chickenpox vaccine uses the live-attenuated Oka strain, originally isolated in 1974 in Japan by Michiaki Takahashi from a child named Oka who had wild-type varicella-zoster virus (VZV). The Oka strain has since been administered to hundreds of millions of children worldwide and is the basis of every licensed varicella vaccine in the United States.
True anaphylaxis after Varivax is rare, at roughly 1.2 cases per million doses distributed in VAERS data and 5.8 per million administered in CDC Vaccine Safety Datalink data. Most of these reactions, on careful allergy workup, are attributed to gelatin IgE rather than to the virus, the cell substrate, or neomycin. Unlike MMR, Varivax is grown in MRC-5 human diploid cell cultures — not chick embryo fibroblasts — which means it contains zero egg protein. Egg allergy is NOT a contraindication or precaution to Varivax at any level.
Readers commonly confuse Varivax with the modern zoster vaccine Shingrix. They should not. Varivax is live-attenuated, pediatric, and gelatin-containing; Shingrix is recombinant, adult, and contains no gelatin or live virus. The detailed comparison is on the companion zoster vaccine page.
Symptoms of Varicella Vaccine Allergic Reactions
Recognizing symptoms early helps you get the right treatment faster.
Injection-site soreness
mildMild redness, swelling, and tenderness at the deltoid or thigh injection site lasting 1 to 3 days. Common and benign.
Vaccine-strain varicelliform rash
mildA handful of vesicular lesions appearing 7 to 21 days after Varivax in 3 to 5% of recipients. An expected response to live-viral replication, not an allergic reaction.
Post-vaccination fever
mildLow-grade fever 1 to 3 weeks after the dose, reflecting live-attenuated viral replication. Non-allergic.
Urticaria (hives)
moderateItchy wheals appearing within minutes of injection, classic for IgE-mediated gelatin reactions. Warrants observation and epinephrine if progressive.
Angioedema
severeDeep swelling of the lips, tongue, or throat. Airway involvement is an emergency requiring immediate intramuscular epinephrine.
Bronchospasm
severeWheezing, cough, and chest tightness within minutes of injection — more likely in patients with baseline asthma.
Anaphylaxis
severeMulti-system allergic reaction with airway, breathing, or cardiovascular compromise. Rare at roughly 1.2 per million doses distributed but reversible with prompt epinephrine.
Febrile seizure (MMRV first dose)
moderateSlightly higher febrile seizure rate after first-dose MMRV (ProQuad) in children 12 to 47 months vs separate MMR and Varivax injections.
When to see a doctor
Immediate IgE-mediated reactions produce the classic constellation of allergy signs within minutes of the injection: hives, angioedema, wheezing, and in severe cases anaphylaxis with hypotension and loss of consciousness. These events warrant immediate intramuscular epinephrine and emergency observation. Mild injection-site redness and tenderness are common and non-allergic. A vaccine-strain varicelliform rash — a few scattered vesicular lesions, sometimes limited to the injection site — appears in approximately 3 to 5% of Varivax recipients 7 to 21 days after the dose. This is a mild, expected response to live-viral replication and is NOT an allergic reaction. In rare cases, vaccine-strain VZV can establish latency and later reactivate as zoster, though the rate is substantially lower than after wild-type infection. Any severe immediate reaction should trigger VAERS reporting and allergist referral for excipient workup.
Varicella Vaccine and Asthma
Asthma itself is not a precaution or contraindication to Varivax — children and adults with well-controlled asthma can receive the routine 2-dose schedule without modifications. The indirect link to vaccine allergy runs through atopy: patients with significant eczema, food allergies, and asthma share a higher baseline probability of gelatin IgE, which is the clinically relevant pre-screen question. Patients using systemic corticosteroids for asthma control raise a separate concern. High-dose systemic steroids (≥2 mg/kg/day of prednisone or equivalent for 14 days or more) are a contraindication to live-attenuated vaccines including Varivax. Inhaled corticosteroids at standard asthma doses are NOT a contraindication. Discuss current medication history with the prescribing clinician before any live-virus dose.
Complications of Varicella Vaccine Reactions
Acute anaphylaxis is rare and nearly always reversible with prompt intramuscular epinephrine and supportive care. More practically common complications include missed protection from accidental vaccine avoidance (usually driven by mislabeled allergies or outdated guidance), and the small risk of vaccine-strain VZV reactivation as herpes zoster years or decades later. Vaccine-strain zoster is generally milder than wild-type zoster and responds to standard antiviral therapy. In rare cases involving severely immunocompromised patients who receive the live-attenuated vaccine inappropriately, disseminated vaccine-strain varicella can occur. This is why the contraindications in immunocompromise are strict and are individually reviewed with the patient's specialist before any dose.
Anaphylaxis
Rapid multi-system allergic reaction, rare at approximately 1.2 per million doses distributed. Reversible with intramuscular epinephrine.
Vaccine-strain herpes zoster
Reactivation of latent vaccine-strain VZV as shingles years or decades later. Rate is lower than after wild-type infection and responds to standard antiviral treatment.
Febrile seizures (MMRV first dose)
Slightly higher rate of febrile seizures after first-dose MMRV compared to separate MMR and Varivax injections in children 12 to 47 months.
Disseminated vaccine-strain VZV
Extremely rare in properly screened patients but can occur in immunocompromised individuals inadvertently vaccinated. Stringent contraindication enforcement prevents this.
Causes of Varicella Vaccine Reactions
The dominant cause of Varivax anaphylaxis is hydrolyzed gelatin, present at 8.3 to 12.0 mg per dose — a dose range somewhat lower than the 14.5 mg in MMR but still in the clinically significant zone for patients with gelatin IgE. A patient who has reacted to MMR because of gelatin will very likely react to Varivax for the same reason, and specialists evaluate the two products as a single allergic exposure class. Secondary excipients include trace neomycin (usually a Type IV contact dermatitis issue, NOT a contraindication unless anaphylactic), monosodium L-glutamate, sucrose, EDTA, and fetal bovine serum.
How it works
Varicella vaccine anaphylaxis follows the classic Type I IgE pathway. Prior dietary gelatin exposure sensitizes atopic individuals, who generate IgE antibodies against bovine and porcine gelatin peptides. When the vaccine delivers a substantial subcutaneous dose of hydrolyzed gelatin, surface-bound IgE on mast cells and basophils cross-links, triggering rapid histamine, tryptase, leukotriene, and platelet-activating factor release. Clinical signs — urticaria, angioedema, bronchospasm, hypotension — appear within minutes. The VZV viral antigen itself stimulates the intended adaptive immune response (T-cell memory and IgG antibody production) and is not a meaningful allergic trigger.
The cell substrate story is distinctive. Varivax is produced in MRC-5, a human diploid cell line derived in 1966 from fetal lung tissue and widely used in viral vaccine production. This choice matters for allergy because MRC-5 contains no egg protein — readers worried about MMRV (which combines MMR and Varivax) should know that the measles and mumps components, grown in chick embryo fibroblasts, are the only avian-cell-substrate components in the combined product, and even there the residual ovalbumin is at the nanogram level and clinically insignificant.
Alpha-gal syndrome patients (sensitized to the mammalian carbohydrate galactose-alpha-1,3-galactose through tick bites) may be at additional risk because porcine-derived hydrolyzed gelatin shares epitopes with mammalian meat proteins.
Risk factors to watch for
Gelatin food allergy
Prior reactions to gummy candies, gelatin desserts, marshmallows, or gelatin-capsule supplements are the single strongest predictor of Varivax allergy and warrant pre-vaccination allergist review.
Prior MMR or other gelatin-vaccine reaction
Prior anaphylaxis to MMR, intranasal FluMist, RabAvert, or YF-VAX suggests shared gelatin IgE and applies to Varivax.
Alpha-gal syndrome
Patients sensitized to mammalian carbohydrate through tick bites may cross-react to porcine gelatin and should be evaluated before any gelatin-containing vaccine.
Severe immunocompromise
Active chemotherapy, post-transplant immunosuppression, high-dose corticosteroids, and advanced HIV are contraindications to the live-attenuated vaccine because of risk of disseminated vaccine-strain infection.
Pregnancy
Live-attenuated varicella vaccine is contraindicated in pregnancy. Women should avoid conception for 4 weeks after a dose and defer vaccination when pregnant until the post-partum period.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Varicella Vaccine Allergy
Suspected Varivax allergy requires allergist evaluation — not at-home testing. The workup mirrors the MMR allergy approach because the dominant excipient is the same: gelatin. Start with a detailed history covering prior gelatin food reactions, prior vaccine anaphylaxis, and the timing and symptoms of the event in question. First-line laboratory testing is serum gelatin-specific IgE via ImmunoCAP. Skin prick and intradermal testing with the Varivax product itself is performed in a specialist clinic if IgE testing is inconclusive. Neomycin testing — by patch test for contact dermatitis or by prick/intradermal for suspected anaphylaxis — is added when the history suggests antibiotic sensitization. Serum tryptase drawn within a few hours of an acute event objectively supports the diagnosis of true anaphylaxis, and baseline tryptase weeks later excludes systemic mastocytosis. At-home testing like Curex's 40+ environmental allergen panel (5 days, insurance accepted) can characterize background atopy, but suspected gelatin, neomycin, or polysorbate 80 allergy requires allergist evaluation — specific IgE testing or skin testing under observation. Vaccine excipient IgE is not part of any at-home allergy panel.
Gelatin-specific IgE (ImmunoCAP)
A blood test for IgE antibodies against bovine and porcine gelatin. The most productive first-line test for suspected Varivax or MMR allergy because gelatin is the dominant excipient allergen in both products.
Skin prick and intradermal testing with Varivax
Graded testing with the actual vaccine product, performed in an allergy clinic with full rescue equipment. A negative graded protocol allows cautious administration of a full dose.
Serum tryptase (acute)
Drawn within 1 to 4 hours of an acute reaction, elevated tryptase supports true anaphylaxis. Baseline tryptase weeks later excludes mastocytosis.
VZV IgG serology
A blood test documenting immunity to varicella-zoster virus — used to determine whether an adult with uncertain vaccination history is already immune and does not need vaccination.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizManaging Varicella Vaccine Reactions
See how different approaches stack up for managing your allergy symptoms long-term.
Acute allergic reactions to Varivax are treated like any other vaccine anaphylaxis: intramuscular epinephrine first, supplemental oxygen, IV fluids for hypotension, and observation for a biphasic reaction over 4 to 6 hours. Antihistamines and corticosteroids are adjuncts that do NOT substitute for epinephrine. For patients with confirmed gelatin IgE who still need varicella protection, supervised graded dosing in an allergist's office succeeds in most reported cases.
Expected post-vaccination responses — mild fever, faint rash 7 to 21 days after the dose, injection-site tenderness — do not require specific treatment beyond symptomatic care. These events are NOT contraindications to subsequent doses and should be documented precisely in the medical record to avoid cascading 'vaccine allergy' labels that block future protection.
Intramuscular epinephrine (acute)
First-line treatment for any vaccine anaphylaxis, delivered into the anterolateral thigh at weight-based dosing. Every vaccination site should stock auto-injectors.
Epinephrine (EpiPen, Auvi-Q, generic auto-injector)
Life-saving when administered promptly
Oral antihistamines (adjunct)
Second-line for cutaneous symptoms during acute reactions. Do NOT replace epinephrine in anaphylaxis.
Cetirizine, diphenhydramine, fexofenadine
Useful for hives and itch only
Supervised graded Varivax dosing
For patients with confirmed Varivax or gelatin anaphylaxis who still need varicella protection, the allergist administers the dose in fractional increments with rescue medications prepared.
Varivax in graded fractions (typically 10/10/20/60%)
Successful in most published cases under specialist supervision
Post-exposure varicella immunoglobulin (VariZIG)
Passive immunoprophylaxis for high-risk susceptible individuals exposed to varicella — typically immunocompromised patients, pregnant women, and neonates born to mothers with peripartum chickenpox. Not a substitute for routine vaccination.
Varicella zoster immune globulin (VariZIG)
Reduces severity and duration of varicella when given within 10 days of exposure
Acyclovir antiviral therapy
Oral or IV acyclovir for severe vaccine-strain or wild-type varicella in high-risk patients. Rarely needed after routine vaccination but used for disseminated vaccine-strain disease in immunocompromised recipients.
Acyclovir, valacyclovir
Evidence-based for wild-type and vaccine-strain VZV
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Allergen Immunotherapy and Varicella Vaccine Allergy
Instead of masking symptoms, immunotherapy retrains your immune system.
Unlike hay fever or dust mite asthma, vaccine component allergy is not treated with chronic allergen immunotherapy. SCIT (allergy shots) and SLIT (sublingual allergy drops) are designed to induce long-term tolerance to environmental aeroallergens — pollens, dust mites, molds, pet dander — that patients encounter repeatedly over years. No SCIT or SLIT protocol exists or is FDA-approved for gelatin, neomycin, or any vaccine excipient. For patients with confirmed gelatin IgE who require Varivax, the relevant intervention is single-session vaccine desensitization in an allergist's office. This involves graded incremental dosing with full rescue preparedness, completed in a few hours, and is clinically distinct from the years-long maintenance model of conventional immunotherapy. Curex's sublingual immunotherapy drops (plan-specific pricing (https://getcurex.com/learn/curex-pricing)) treat IgE-mediated environmental allergies — dust mites, pollens, pet dander, molds. In a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., peer-reviewed in Frontiers in Allergy in 2026), clinically meaningful symptom improvement rose to 45% of patients by two years, quality-of-life improvement reached 90.7%, adherence stayed above 90%, and no anaphylaxis was reported. Vaccine-component allergy is outside this scope; patients with confirmed gelatin IgE work with an allergist for desensitization protocols when vaccination is essential. The two approaches solve different immune problems and cannot be substituted for each other.
Allergist consultation and excipient history
Review of prior gelatin food reactions, prior vaccine anaphylaxis, and the specific event in question.
Gelatin-specific IgE testing
Serum blood testing, sometimes combined with graded skin testing when results are inconclusive.
Risk-benefit assessment
Weigh exposure risk — outbreak, immunocompromised household members, travel — against reaction severity.
Supervised graded dosing in clinic
Single-session graded administration with rescue medications ready, followed by extended observation.
“Published case series report successful graded Varivax administration in the majority of supervised attempts for patients with confirmed gelatin IgE.”
Treat your Varicella Vaccine allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing · Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living With a Confirmed Varivax or Gelatin Allergy
Confirmed Varivax or gelatin allergy requires coordination across providers but rarely prevents future varicella protection in most patients. Keep a written vaccine allergy action plan documenting the specific excipient, carry epinephrine if prescribed, wear medical alert identification, and coordinate with school, daycare, dentists, and anesthesiologists who may use gelatin-containing medications or devices. Parents of children with confirmed allergy should discuss household protection strategies: immunizing unaffected family members to reduce household exposure, antiviral prophylaxis after known exposures in susceptible children, and early recognition of wild-type chickenpox symptoms so treatment can start promptly if needed.
Written vaccine action plan
Document the specific excipient, the reaction history, and allergist recommendations. Bring the plan to every medical visit.
Household vaccination strategy
Immunize unaffected family members to reduce household exposure risk to the patient with confirmed allergy.
Medical alert identification
A bracelet or wallet card listing the allergy helps emergency responders if the patient cannot speak.
Post-exposure planning
Confirmed susceptible patients exposed to wild-type varicella may benefit from VariZIG or antiviral prophylaxis — discuss with the treating clinician promptly.
When Do Varicella Vaccine Reactions Occur?
Varivax is administered year-round on the US schedule: first dose at 12 to 15 months of age, second dose at 4 to 6 years. Catch-up vaccination for older unvaccinated children and susceptible adults is distributed across the calendar. There is no seasonal clustering of vaccine reactions — the per-dose risk is constant across the year. Historical wild-type chickenpox followed a strong late-winter-to-spring seasonal pattern before universal vaccination, but that pattern does not apply to vaccine allergic reactions, which follow administration timing rather than viral ecology. True IgE-mediated reactions begin within 15 minutes of the injection and almost always within one hour, which is why vaccination guidelines recommend a 15 to 30-minute post-dose observation period. Mild injection-site soreness, low-grade fever, and a faint varicelliform rash appearing 7 to 21 days after Varivax are expected responses to live-viral replication and are NOT allergic reactions.
January - December
medium intensity
Preventing Varicella Vaccine Reactions
Prevention of Varivax reactions starts with pre-vaccination screening focused on the actual risk factors: prior gelatin food anaphylaxis, prior vaccine anaphylaxis, true anaphylactic neomycin allergy, pregnancy, and severe immunocompromise. Egg allergy is NOT a relevant pre-screen for Varivax at any level — the vaccine contains no egg protein because it is grown in MRC-5 human diploid cells. Every vaccination site should stock epinephrine, train staff in immediate reaction recognition, and enforce a 15 to 30-minute post-dose observation window for atopic patients. Document reactions accurately in the medical record using precise clinical language — 'injection-site soreness,' 'expected post-vaccine varicelliform rash' — rather than broad 'vaccine allergy' labels that block future protection.
Screen for gelatin food reactions
Prior reactions to gummy candies, marshmallows, or gelatin desserts are the single most useful pre-Varivax history question.
Confirm non-pregnant status
Live-attenuated Varivax is contraindicated in pregnancy. Ask all women of childbearing age before dosing, and advise 4-week post-dose pregnancy avoidance.
Review immunocompromise status
Active chemotherapy, post-transplant immunosuppression, and high-dose systemic steroids contraindicate Varivax. Coordinate with the treating specialist before any dose.
Observe 15–30 minutes post-dose
Immediate allergic reactions nearly always appear within 15 minutes. A short observation window catches events when epinephrine is most effective.
Prognosis and Outlook
The prognosis for individual patients with suspected Varivax allergy is generally excellent. Acute reactions respond to intramuscular epinephrine, and supervised graded dosing succeeds in most documented cases. Most patients labeled with 'vaccine allergy' can be de-labeled after careful allergist review, or can receive vaccination under supervision when needed. The broader public health prognosis for varicella control in the US is excellent. Universal 2-dose vaccination has driven chickenpox hospitalizations and deaths to historic lows, with corresponding reductions in wild-type zoster expected over the coming decades as the vaccinated cohort ages. Maintaining high coverage depends on accurate allergy labeling and avoidance of unnecessary exemptions.
Key takeaways
Varivax contains 8.3 to 12.0 mg of hydrolyzed gelatin — the dominant allergen concern.
Varivax is grown in MRC-5 human diploid cells and contains no egg protein at all.
The Oka strain is live-attenuated, contraindicated in pregnancy and severe immunocompromise.
Varivax is completely different from Shingrix — same virus, opposite excipient profiles.
True vaccine anaphylaxis is rare at roughly 1.2 per million doses and nearly always reversible with epinephrine.
Diet and Gelatin Sensitization
Dietary gelatin exposure is how most people become sensitized to gelatin in the first place. Gummy candies, gelatin desserts, gelatin-capsule supplements, marshmallows, and some yogurts are common sources. Routine gelatin avoidance in the general population has no demonstrated benefit in preventing vaccine reactions, but patients with confirmed gelatin IgE should work with their allergist on individualized dietary guidance alongside vaccine planning.
Foods to limit
Gelatin-based candies
Gummy bears, gummy worms, marshmallows, and similar products contain concentrated gelatin that can trigger reactions in sensitized individuals.
Gelatin dessert mixes
Jello and similar products are predominantly gelatin and a common exposure route for childhood sensitization.
Gelatin capsule supplements
Many OTC vitamins and supplements use gelatin capsules; patients with confirmed IgE should request vegetarian (HPMC) alternatives.
The varicella vaccine reaction question almost always resolves to gelatin — not the virus, not egg protein, not neomycin. When parents tell me their child 'reacted to the chickenpox vaccine,' gelatin IgE is the first test I order.
Frequently Asked Questions
No. Varivax contains no egg protein whatsoever. The varicella-zoster virus (Oka strain) used in the vaccine is propagated in MRC-5 human diploid cell cultures — a mammalian cell line derived from fetal lung tissue — rather than the chick embryo cultures used for measles and mumps. This means egg allergy, at any severity, is NOT a contraindication or precaution for Varivax or for the varicella component of MMRV. Parents and clinicians concerned about combining MMR and Varivax in the same visit should know that even the MMR components have negligible residual ovalbumin (0 to 1 nanogram) and are also safe in egg allergy per current ACIP guidance. The real allergen concern for both products is hydrolyzed gelatin.
Medical References
- [1]McNeil MM, Weintraub ES, Duffy J, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol 2016;137(3):868-878.
- [2]Kelso JM, Greenhawt MJ, Li JT, et al. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol 2012;130(1):25-43.
- [3]Pool V, Braun MM, Kelso JM, et al. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after MMR in the United States. Pediatrics 2002;110(6):e71.
- [4]Sakaguchi M, Nakayama T, Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines. J Allergy Clin Immunol 1996;98(6 Pt 1):1058-1061.
- [5]CDC Advisory Committee on Immunization Practices (ACIP). General Best Practice Guidelines for Immunization. Updated 2023.
- [6]Wood RA, Berger M, Dreskin SC, et al. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics 2008;122(3):e771-777.
- [7]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [8]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Varicella Vaccine allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.